Company Profile

Viridae Clinical Sciences USA
Profile last edited on: 9/24/2013      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1994
First Award
2000
Latest Award
2001
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3130 Highland Avenue 3rd Floor
Cincinnati, OH 45219
Location: Single
Congr. District: 01
County: Hamilton

Public Profile

Though with Cincinnati, OH based facilities, Viridae Clinical Sciences is a Canadian owned firm (eligibility) engaged in antiviral research and testing, specializing in herpes and hepatitis. Viridae consists of a full-service Contract Research Organization (CRO), a fully accredited virology laboratory and a clinic that serves as an investigator site for virology based clinical trials. Viridae is a wholly Canadian owned Contract Research Organization committed to providing efficient, cost-effective clinical research services to the international pharmaceutical industry. Viridae uniquely specializes in the management of community-based clinical trials, with a special focus on the prevention and treatment of viral and STD diseases. Services include drug development strategic planning and advice; preparation of regulatory documents; protocol design and study concepts; identification and recruitment of expert clinical centres globally; training of study personnel; in-house 1,2,3 clinical trials etc. Viridae is involved in the establishment, organization, conduct and management of international multi-centre clinical trials programs for North American, European and Asian pharmaceutical companies. Viridae has an in-house, fully accredited virology laboratory offering complete services ranging from processing viral cultures and antigen specimens to specialized testing for herpes and hepatitis viruses. Lab standards exceed GCP guidelines.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2001 2 NIH $900,000
Project Title: Development of Dendrimers as Vaginal Microbicides

Key People / Management

  Stephen L Sacks -- President

Company News

There are no news available.